TOPEC Rebrands as Global Learning Collaborative (GLC) to Reflect Continued Corporate Growth
The Omnia-Prova Education Collaborative (TOPEC) announces new name, reflecting growth in corporate subsidiaries, educational collaborations, and scientific areas of expertise.
FORT WASHINGTON, Pa., July 17, 2019 /PRNewswire-PRWeb/ -- The Omnia-Prova Education Collaborative (TOPEC) today announced the new brand for its suite of CME subsidiaries: Global Learning Collaborative (GLC).
"The past few years represent the highest rate of growth in our CME enterprise, including growth in subsidiaries, scientific teams, leadership, and educational collaborations," said Rob Braun, President of GLC. "The GLC brand reflects our belief in the power of CME to change the practice of medicine and impact patient outcomes."
GLC is Accredited with Commendation by the Accreditation Council for Continuing Medical Education (ACCME) – the highest achievable level. Only 5% of for-profit accredited organizations receive Commendation status.
Areas of expertise of the GLC companies include:
- Omnia Education provides education on diseases and conditions impacting the female patient.
- Prova Education provides education on oncology, ophthalmology, rheumatology, and other key specialty areas.
- Medtelligence provides education in the cardiovascular arena.
- AGILE delivers education on five continents and seven languages, helping shape knowledge, awareness, and performance of clinicians worldwide.
ABOUT GLOBAL LEARNING COLLBORATIVE
Global Learning Collaborative (GLC) is a member of the US HealthConnect Inc. group of companies. GLC is the parent organization to Omnia Education, Prova Education, Medtelligence, and the Academy for Global Interprofessional Learning & Education (AGILE). GLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. More information is available at http://www.GLC.healthcare.
SOURCE The Omnia-Prova Education Collaborative (TOPEC)

Share this article